المؤلفون: Olszewski AJ; Lifespan Cancer Institute, The Warren Alpert Medical School of Brown University, Providence, RI., Jakobsen LH; Department of Haematology, Aalborg University Hospital, Aalborg, Denmark., Collins GP; Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom., Cwynarski K; Department of Haematology, University College London Hospitals NHS Foundation Trust, London, United Kingdom., Bachanova V; Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN., Blum KA; Winship Cancer Institute, Emory University, Atlanta, GA., Boughan KM; Adult Hematologic Malignancies and Stem Cell Transplant Section, University Hospitals Seidman Cancer Center, Cleveland, OH., Bower M; National Centre for HIV Malignancy, Chelsea and Westminster Hospital, London, United Kingdom., Dalla Pria A; National Centre for HIV Malignancy, Chelsea and Westminster Hospital, London, United Kingdom., Danilov A; Toni Stephenson Lymphoma Center, City of Hope Comprehensive Cancer Center, Duarte, CA., David KA; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ., Diefenbach C; Perlmutter Cancer Institute, NYU Langone Health, New York, NY., Ellin F; Department of Clinical Sciences Lund, Oncology and Pathology, Lund University, Lund, Sweden., Epperla N; The Ohio State University James Comprehensive Cancer Center, Columbus, OH., Farooq U; Division of Hematology, Oncology, and Blood & Marrow Transplantation, University of Iowa, Iowa City, IA., Feldman TA; John Theurer Cancer Center, Hackensack Meridian Health School of Medicine, Hackensack, NJ., Gerrie AS; BC Cancer Centre for Lymphoid Cancer and The University of British Columbia, Vancouver, British Columbia, Canada., Jagadeesh D; Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH., Kamdar M; University of Colorado Cancer Center, Aurora, CO., Karmali R; Division of Hematology Oncology, Northwestern University, Chicago, IL., Kassam S; King's College Hospital, London, United Kingdom., Kenkre VP; Carbone Cancer Center, University of Wisconsin, Madison, WI., Khan N; Fox Chase Cancer Center, Philadelphia, PA., Kim SH; Division of Hematology Oncology, Rush University Medical Center, Chicago, IL., Klein AK; Division of Hematology and Oncology, Tufts Medical Center, Boston, MA., Lossos IS; Division of Hematology, Department of Medicine, Sylvester Comprehensive Cancer Center, University of Miami School of Medicine, Miami, FL., Lunning MA; University of Nebraska Medical Center, Omaha, NE., Martin P; Weill Cornell Medicine-New York Presbyterian Hospital, New York, NY., Martinez-Calle N; Nottingham University Hospitals, NHS Trust, Nottingham, United Kingdom., Montoto S; Department of Haemato-oncology, St Bartholomew's Hospital, Barts Health NHS Trust, London, United Kingdom., Naik S; Penn State Cancer Institute, Penn State Hershey Medical Center, Hershey, PA., Palmisiano N; Division of Hematologic Malignancies and Hematopoietic Stem Cell Transplantation, Department of Medical Oncology, Thomas Jefferson University, Philadelphia, PA., Peace D; Division of Hematology/Oncology, Department of Medicine, University of Illinois College of Medicine, Chicago, IL., Phillips EH; Division of Cancer Sciences, University of Manchester, Manchester, United Kingdom., Phillips TJ; University of Michigan Comprehensive Cancer Center, Dexter, MI., Portell CA; Division of Hematology/Oncology, University of Virginia, Charlottesville, VA., Reddy N; Vanderbilt University Medical Center, Nashville, TN., Santarsieri A; Department of Haematology, Cambridge University Hospitals NHSFT, Cambridge, United Kingdom., Sarraf Yazdy M; Georgetown University Hospital, Washington, DC., Smeland KB; Department of Oncology, Oslo University Hospital, Oslo, Norway., Smith SE; Loyola University Medical Center, Maywood, IL., Smith SD; University of Washington/Fred Hutchinson Cancer Research Center, Seattle, WA., Sundaram S; Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY., Zayac AS; Lifespan Cancer Institute, The Warren Alpert Medical School of Brown University, Providence, RI., Zhang XY; Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom., Zhu C; Department of Haematology, University College London Hospitals NHS Foundation Trust, London, United Kingdom., Cheah CY; Linear Clinical Research and Sir Charles Gairdner Hospital, Perth, Australia., El-Galaly TC; Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark., Evens AM; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ.

المصدر: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2021 Apr 01; Vol. 39 (10), pp. 1129-1138. Date of Electronic Publication: 2021 Jan 27.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Burkitt Lymphoma/*drug therapy , Outcome Assessment, Health Care/*statistics & numerical data, Adult ; Australia ; Canada ; Cohort Studies ; Europe ; Female ; Humans ; Kaplan-Meier Estimate ; Male ; Middle Aged ; Multivariate Analysis ; Outcome Assessment, Health Care/methods ; Prognosis ; Rituximab/administration & dosage ; United States